{"@id":"https://bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://cn.bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","json":"https://cn.bioecon.ru/api/v1/technology/ai-based-ada-immunogenicity-prediction/index.json"},"id":"ai-based-ada-immunogenicity-prediction","industries":["diagnostics","medtech-devices","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/diagnostics/","https://bioecon.ru/industries/medtech-devices/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/chitose/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/ecowin/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/grupo-hidrogood/"]},"maturity":7,"name":"基于人工智能与扁桃体类器官的生物药抗药抗体（ADA）免疫原性预测平台","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"治疗性抗体三维结构免疫原性表位扫描"},{"n":2,"title":"HLA-II类分子泛等位基因亲和力深度预测"},{"n":3,"title":"人源扁桃体微型免疫类器官离体激发验证"},{"n":4,"title":"计算机辅助去免疫化隐形突变工程化改造"}],"summary":"融合三维蛋白质结构几何深度学习、HLA-II类分子亲和力预测算法与人类离体扁桃体类器官免疫应答模型，在先导抗体优化阶段精准预测临床抗药抗体（ADA）产生风险与CD4+ T细胞激活潜能。","url":"/technology/ai-based-ada-immunogenicity-prediction/","verified":"2026-11-22"}